Matches in Wikidata for { <http://www.wikidata.org/entity/Q37125405> ?p ?o ?g. }
- Q37125405 description "article científic" @default.
- Q37125405 description "article scientifique" @default.
- Q37125405 description "articolo scientifico" @default.
- Q37125405 description "artigo científico" @default.
- Q37125405 description "artículu científicu espublizáu en 2008" @default.
- Q37125405 description "bilimsel makale" @default.
- Q37125405 description "scientific article published on 06 June 2008" @default.
- Q37125405 description "vedecký článok" @default.
- Q37125405 description "vetenskaplig artikel" @default.
- Q37125405 description "videnskabelig artikel" @default.
- Q37125405 description "vědecký článek" @default.
- Q37125405 description "wetenschappelijk artikel" @default.
- Q37125405 description "wissenschaftlicher Artikel" @default.
- Q37125405 description "наукова стаття, опублікована в червні 2008" @default.
- Q37125405 description "научни чланак" @default.
- Q37125405 description "مقالة علمية نشرت في 06 يونيو 2008" @default.
- Q37125405 name "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 name "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 name "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 type Item @default.
- Q37125405 label "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 label "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 label "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 prefLabel "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 prefLabel "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 prefLabel "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.
- Q37125405 P1433 Q37125405-EE85B787-7C41-4703-B4A2-3ECEC97E36F1 @default.
- Q37125405 P1476 Q37125405-03CB4278-6340-41B8-8607-71C33BD74503 @default.
- Q37125405 P2093 Q37125405-12BF805A-76D4-4CA2-9A83-31338B6F81E8 @default.
- Q37125405 P2093 Q37125405-2B120F11-E877-4229-B3C9-FDC205295288 @default.
- Q37125405 P2093 Q37125405-51E8B818-B108-4F0A-91E6-249246DF708A @default.
- Q37125405 P2093 Q37125405-AF5D5BAD-3E5D-4683-922D-FF412BE54CAB @default.
- Q37125405 P2093 Q37125405-B19CC077-F38A-4B21-B935-F26D412BFB41 @default.
- Q37125405 P2093 Q37125405-C230233D-2534-437A-AE6B-AE1DA53DD980 @default.
- Q37125405 P2093 Q37125405-D90F85E5-E296-46F5-875B-89F2D5D7DEBB @default.
- Q37125405 P2860 Q37125405-01176EA4-80A7-4010-A673-45118F43D5E5 @default.
- Q37125405 P2860 Q37125405-05905AEA-8F6E-48F9-A79C-66CF2CD13117 @default.
- Q37125405 P2860 Q37125405-0D1EB0B0-E2A4-4CB2-B704-DA33F9BBB711 @default.
- Q37125405 P2860 Q37125405-149DED36-C06C-4E87-9666-745C6F1CFC45 @default.
- Q37125405 P2860 Q37125405-16F61228-E518-4A2E-A61D-322144D9C918 @default.
- Q37125405 P2860 Q37125405-1DEE180C-6F1D-4A34-8928-25157CBB068C @default.
- Q37125405 P2860 Q37125405-31D44ED9-36D1-4BFF-AF6F-6F9CA8A99DF4 @default.
- Q37125405 P2860 Q37125405-351E98BF-EA34-42CD-A99F-6D38E289C1E4 @default.
- Q37125405 P2860 Q37125405-3FDD9464-BD80-4EF4-A85D-C19AC4D19BBA @default.
- Q37125405 P2860 Q37125405-414644E3-7D41-4303-AC92-8BB7630C1A34 @default.
- Q37125405 P2860 Q37125405-41B6BD08-996E-4A1D-8F69-AF46F9ACA52F @default.
- Q37125405 P2860 Q37125405-4AF5F5CF-F5F0-44C2-8860-8CBD3E7A2511 @default.
- Q37125405 P2860 Q37125405-50385670-4EDD-4705-9EF0-71574D57B79D @default.
- Q37125405 P2860 Q37125405-55DE366F-5EA0-485E-A275-2AC5070397BD @default.
- Q37125405 P2860 Q37125405-678346F9-63D2-40AC-A855-16318B6BC412 @default.
- Q37125405 P2860 Q37125405-6947033C-9E89-46DD-BDD3-48B9A53771C0 @default.
- Q37125405 P2860 Q37125405-6C0DBC6F-4CA9-467A-ACAD-FED3BD94F584 @default.
- Q37125405 P2860 Q37125405-72A6B737-ED2E-4B74-BE76-134B22F01ADA @default.
- Q37125405 P2860 Q37125405-7391B0AB-9D29-4BB5-9239-3DD957966FD4 @default.
- Q37125405 P2860 Q37125405-7D0D2505-17BD-464C-846D-062C634513AF @default.
- Q37125405 P2860 Q37125405-8A7E34A9-24E7-42BE-9E66-093E36935D00 @default.
- Q37125405 P2860 Q37125405-8AD2C05D-5FC2-4FF8-85AE-8B3EBE5E4DB3 @default.
- Q37125405 P2860 Q37125405-8E64C52E-6A36-4F31-B184-0996299A7B6C @default.
- Q37125405 P2860 Q37125405-90C16055-D61A-4749-AC6F-0856E111441F @default.
- Q37125405 P2860 Q37125405-9143DCAC-6A18-4AF1-A37F-2F4BEB4B920D @default.
- Q37125405 P2860 Q37125405-9AD533B6-3A05-4CF4-B2B7-0FDA1C3D284D @default.
- Q37125405 P2860 Q37125405-9DAFB75D-E847-451D-849E-C32C8068DC2A @default.
- Q37125405 P2860 Q37125405-9EF1B18F-580E-48EB-849B-B3C2AA60B408 @default.
- Q37125405 P2860 Q37125405-A950E8D7-1E2C-48B6-9D7E-28FAE7D85755 @default.
- Q37125405 P2860 Q37125405-AB9EAF46-9FED-47DD-AC34-E7FCD4FB0ABF @default.
- Q37125405 P2860 Q37125405-AC3FD6BF-1201-466B-B5F7-ECD74CC8A5FB @default.
- Q37125405 P2860 Q37125405-AD4B2EAB-696D-487C-9509-C04F1B53A79F @default.
- Q37125405 P2860 Q37125405-B57A088E-55BC-44FC-979E-5CC568116C51 @default.
- Q37125405 P2860 Q37125405-BB20EFC1-062E-4FF6-B35D-FBF381AE84D6 @default.
- Q37125405 P2860 Q37125405-BDEABA27-1FFF-4BF9-9939-EE6ECF49043C @default.
- Q37125405 P2860 Q37125405-C9428816-EA4C-4086-9D5B-BC60D10EF06B @default.
- Q37125405 P2860 Q37125405-CEAF7E4D-621C-4766-BF2B-429EBB6C2EDA @default.
- Q37125405 P2860 Q37125405-D05791BC-B1C7-47D6-B99D-9AA2025ABFA7 @default.
- Q37125405 P2860 Q37125405-D21C8F9A-A120-4073-84E1-527D1F9E621F @default.
- Q37125405 P2860 Q37125405-D99E847D-DC1C-4D57-9F5A-B64BFF16B40E @default.
- Q37125405 P2860 Q37125405-DBF70AE8-A470-4919-86ED-275AFA8C6998 @default.
- Q37125405 P2860 Q37125405-E0990552-5FB5-48D2-86B5-D1D029E9E0BC @default.
- Q37125405 P2860 Q37125405-E89CBE1B-0C01-48F6-85D4-159308894B61 @default.
- Q37125405 P2860 Q37125405-E99578D0-C7DE-48CD-959A-7193F59051EE @default.
- Q37125405 P2860 Q37125405-F416A381-45DF-4967-9A3E-E4D68C762912 @default.
- Q37125405 P2860 Q37125405-F5D9E02E-4478-4EA0-810B-07E9F895203C @default.
- Q37125405 P2860 Q37125405-FD81A050-7B7A-4573-9079-2F19E97405FC @default.
- Q37125405 P2860 Q37125405-FF22C21C-A4DC-4206-AF98-D05D74611F12 @default.
- Q37125405 P304 Q37125405-C772C079-F1B6-48C5-9AEB-9834B9E65D5A @default.
- Q37125405 P31 Q37125405-0DE9D0A0-80DA-4CDF-B859-F3524DC6B9CD @default.
- Q37125405 P356 Q37125405-54D31A30-D983-47A6-B21F-0FD35786D62B @default.
- Q37125405 P407 Q37125405-230DF0BF-2D78-46BB-963C-075558B8DAAA @default.
- Q37125405 P433 Q37125405-869760AF-A797-4EF4-8DE2-C43A62782D4B @default.
- Q37125405 P478 Q37125405-D3815372-81C2-4063-AFC6-C6DB8B0549A0 @default.
- Q37125405 P577 Q37125405-5B9AF1A0-0B83-49C5-A658-F0F11408820B @default.
- Q37125405 P5875 Q37125405-4C08045A-219A-4D17-ADE5-23D49FE02A45 @default.
- Q37125405 P698 Q37125405-ED6DF2B9-63C0-44D0-B5BF-41954D38700A @default.
- Q37125405 P921 Q37125405-0400112A-27E8-4332-B02D-E1625C12AE25 @default.
- Q37125405 P921 Q37125405-10CD7CDF-C9AF-43B1-A033-1F27A1988042 @default.
- Q37125405 P921 Q37125405-C8C73248-EFE4-4D42-B027-D637EFD6289F @default.
- Q37125405 P932 Q37125405-21A7D314-BBA3-488A-9156-F728681726BD @default.
- Q37125405 P356 J.1365-2141.2008.07181.X @default.
- Q37125405 P698 18540943 @default.
- Q37125405 P1433 Q4970200 @default.
- Q37125405 P1476 "Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes" @default.